Chouhan, M., Kumar, M., Dwivedi, V. D., Kashyap, V. K., Singh, H. N., & Kumar, S. (2025). Harnessing Natural Product Compounds to Target Dormancy Survival Regulator (DosR) in Latent Tuberculosis Infection (LTBI): An In Silico Strategy Against Dormancy. Advances in Respiratory Medicine, 93(3), 19. https://doi.org/10.3390/arm93030019

Villa, C. H., Biondich, P., Draper, N. L., Dores, G. M., Storch, E., Chada, K., Wong, H., Whitaker, B., Obidi, J., Vossoughi, S., Soares, A., Schilling, L. M., Natarajan, K., Goodman, M., Purkayastha, S., Zucker, R., Falconer, T., Williams, N., Reich, C., … Shoaibi, A. (2024). Patterns of platelet use evaluated in EHR networks of the Biologics Effectiveness and Safety Initiative, 2012–2018. Transfusion. Portico. https://doi.org/10.1111/trf.18114

Lee, K. E., Sizemore, J. A., Kim, G., Shen, B., & Sands, B. E. (2024). Impact of Biologics and Small-Molecule Agents on Postoperative Complications in IBD: A Systematic Review. Diseases of the Colon & Rectum, 67(S1), S11–S25. https://doi.org/10.1097/dcr.0000000000003222

Servais, L., Day, J. W., De Vivo, D. C., Kirschner, J., Mercuri, E., Muntoni, F., Proud, C. M., Shieh, P. B., Tizzano, E. F., Quijano-Roy, S., Desguerre, I., Saito, K., Faulkner, E., Benguerba, K. M., Raju, D., LaMarca, N., Sun, R., Anderson, F. A., & Finkel, R. S. (2024). Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry. Journal of Neuromuscular Diseases, 11(2), 425–442. https://doi.org/10.3233/jnd-230122

Ao, S., Huang, G., Tang, X., Zhu, Z., Han, J., Wang, F., & Zhai, W. (2023). Anti‐immunoglobulin E provides an additional therapy to conventional steroids for Kimura’s disease. The Journal of Dermatology, 51(4), 602–606. Portico. https://doi.org/10.1111/1346-8138.17021

Olén, O., Smedby, K. E., Erichsen, R., Pedersen, L., Halfvarson, J., Hallqvist-Everhov, Å., Bryder, N., Askling, J., Ekbom, A., Sachs, M. C., Sørensen, H. T., Ludvigsson, J. F., Olsson, M., Myrelid, P., Hjortswang, H., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., … Karling, P. (2023). Increasing Risk of Lymphoma Over Time in Crohn’s Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study. Clinical Gastroenterology and Hepatology, 21(12), 3132–3142. https://doi.org/10.1016/j.cgh.2023.04.001

Patel, R., Negassa, A., Tolu, S. S., Acuna-Villaorduna, A., & Goel, S. (2024). Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer, 23(1), 14-21.e1. https://doi.org/10.1016/j.clcc.2023.10.001

Eriksson, C., Söderling, J., Karlqvist, S., Bröms, G., Everhov, Å. H., Bergemalm, D., Ludvigsson, J. F., Olén, O., & Halfvarson, J. (2023). Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn’s Disease. Digestive Diseases and Sciences, 68(7), 3119–3128. https://doi.org/10.1007/s10620-023-07897-2

Smolen, J. S., Landewé, R. B. M., Bergstra, S. A., Kerschbaumer, A., Sepriano, A., Aletaha, D., Caporali, R., Edwards, C. J., Hyrich, K. L., Pope, J. E., de Souza, S., Stamm, T. A., Takeuchi, T., Verschueren, P., Winthrop, K. L., Balsa, A., Bathon, J. M., Buch, M. H., Burmester, G. R., … van der Heijde, D. (2022). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases, 82(1), 3–18. https://doi.org/10.1136/ard-2022-223356

Brinkley, T. E., Justice, J. N., Basu, S., Bauer, S. R., Loh, K. P., Mukli, P., Ng, T. K. S., Turney, I. C., Ferrucci, L., Cummings, S. R., & Kritchevsky, S. B. (2022). Research priorities for measuring biologic age: summary and future directions from the Research Centers Collaborative Network Workshop. GeroScience, 44(6), 2573–2583. https://doi.org/10.1007/s11357-022-00661-w

Lee, K. E., Faye, A. S., Vermeire, S., & Shen, B. (2022). Perioperative Management of Ulcerative Colitis: A Systematic Review. Diseases of the Colon & Rectum, 65(S1), S5–S19. https://doi.org/10.1097/dcr.0000000000002588

Lawn, R. B., Murchland, A. R., Kim, Y., Chibnik, L. B., Tworoger, S. S., Rimm, E. B., Sumner, J. A., Roberts, A. L., Nishimi, K. M., Ratanatharathorn, A. D., Jha, S. C., Koenen, K. C., & Kubzansky, L. D. (2022). Trauma, psychological distress and markers of systemic inflammation among US women: A longitudinal study. Psychoneuroendocrinology, 145, 105915. https://doi.org/10.1016/j.psyneuen.2022.105915

Bender, B., Oppenheimer, J., George, M., Brown, R., Patel, A., Hill, T., Boe, A., Mayen Herrera, E., Dotiwala, Z., Casciano, J., & Bernstein, J. A. (2022). Assessment of Real-World Escalation to Biologics in US Patients With Asthma. The Journal of Allergy and Clinical Immunology: In Practice, 10(11), 2941–2948. https://doi.org/10.1016/j.jaip.2022.07.016

Palumbo, A., Aluru, V., Battaglia, J., Geller, D., Turry, A., Ross, M., Cristian, A., Balagula, C., Ogedegbe, G., Khatri, L., Chao, M. V., Froemke, R. C., Urbanek, J. K., & Raghavan, P. (2021). Music Upper Limb Therapy–Integrated Provides a Feasible Enriched Environment and Reduces Post-stroke Depression. American Journal of Physical Medicine & Rehabilitation, 101(10), 937–946. https://doi.org/10.1097/phm.0000000000001938

Thunberg, J., Björkqvist, O., Hedin, C. R. H., Forss, A., Söderman, C., Bergemalm, D., Olén, O., Hjortswang, H., Strid, H., Ludvigsson, J. F., Eriksson, C., & Halfvarson, J. (2022). Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. United European Gastroenterology Journal, 10(7), 631–639. Portico. https://doi.org/10.1002/ueg2.12275

Thomsen, G., Burghes, A. H. M., Hsieh, C., Do, J., Chu, B. T. T., Perry, S., Barkho, B., Kaufmann, P., Sproule, D. M., Feltner, D. E., Chung, W. K., McGovern, V. L., Hevner, R. F., Conces, M., Pierson, C. R., Scoto, M., Muntoni, F., Mendell, J. R., & Foust, K. D. (2021). Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue. Nature Medicine, 27(10), 1701–1711. https://doi.org/10.1038/s41591-021-01483-7